Older adults in the US are increasingly dying from unintentional falls
Older U.S. adults are increasingly dying from unintentional falls, according to a new federal report published Wednesday, with white people accounting for the vast majority of the deaths.
From 2003 to 2023, death rates from falls rose more than 70% for adults ages 65 to 74, the report from the U.S. Centers for Disease Control and Prevention said. The rate increased more than 75% for people 75 to 84, and more than doubled for seniors 85 and older.
'Falls continue to be a public health problem worth paying attention to,' said Geoffrey Hoffman, a University of Michigan researcher who was not involved in the new report. 'It's curious that these rates keep rising.'
The CDC researchers did not try to answer why death rates from falls are increasing. But experts say there may be a few reasons, like gradually improving our understanding of the the role falls play in deaths and more people living longer — to ages when falls are more likely to have deadly consequences.
More than 41,000 retirement-age Americans died of falls in 2023, the most recent year for which final statistics based on death certificates are available. That suggests that falls were blamed in about 1 of every 56 deaths in older Americans that year.
More than half of those 41,000 deaths were people 85 and older, the CDC found, and white people accounted for 87% of deaths in the oldest category.
Falls can cause head injuries or broken bones that can lead to permanent disability and trigger a cascade of other health problems. A number of factors can contribute to falls, including changes in hearing and vision and medications that can cause light-headedness.
Death rates varied widely from state to state. In 2023, Wisconsin had the highest death rates from falls, followed by Minnesota, Maine, Oklahoma and Vermont. Wisconsin's rate was more than five times higher than the rate of the lowest state, Alabama.
Ice and wintry weather may partly explain why fatal falls were more common in states in the upper Midwest and New England, but experts also pointed to other things at play, like differences in how well falls are reported and to what extent they are labeled a cause of death.
'We've yet to unravel why you see such differences in state rates,' said Hoffman, who studies falls among the elderly.
Researchers also can't yet explain why white seniors die of falls at higher rates than people in other racial and ethnic groups. In the 85-and-up age group, the death rate for white Americans is two or three times higher than any other group, while older Black people had the lowest fall-related death rate.
'Kind of a flip of the traditional disparity lens,' Hoffman said, referring to the fact that for most other rates of illness and injury, people of color are disproportionately affected.
Staying active can help people avoid falls, experts say.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
24 minutes ago
- CNN
Social Security won't be able to pay full benefits in 2034 if Congress doesn't act
Social Security will not be able to fully pay monthly benefits to tens of millions of retirees and people with disabilities in 2034 if lawmakers don't act to address the program's pending shortfall, according to an annual report released Wednesday by Social Security's trustees. The combined Social Security trust funds – which help support payments to the elderly, survivors and people with disabilities – are expected to be exhausted in 2034, one year earlier than previously forecast, according to the trustees' annual report. At that time, payroll tax revenue and other income sources will only be able to cover 81% of benefits owed. The deterioration in the forecast stems from several factors, including a law passed by Congress last year that increased benefits for certain workers and the trustees' assumption that it will take longer for the nation's fertility rate to recover from historically low levels. Average earnings are expected to grow somewhat more slowly over the coming decade, according to the report. Medicare's fiscal outlook also worsened. Its hospital insurance trust fund, known as Medicare Part A, is expected to be able to cover scheduled inpatient hospital benefits until 2033, compared to 2036 in last year's report from the program's trustees. At that time, Medicare will only be able to pay 89% of total scheduled Part A benefits, which also cover hospice care, short-term skilled nursing facility services and home health services following hospitalizations. The program's trustees project that Medicare's trust fund will be drained sooner because of increased medical spending in 2024, which also raised the forecast for future expenditures. Plus, the trustees raised their assumed growth level of inpatient and hospice services in coming years.
Forbes
24 minutes ago
- Forbes
InnovationRx: The Dangers Of RFK Jr.'s Vaccine Advisory Committee
In this week's edition of InnovationRx, we look at the dangers of RFK Jr.'s vaccine advisory committee, how Trump's visa ban bars foreign doctors, the first FDA-approved transcontinental telesurgery and more. To get it in your inbox, subscribe here. Dr. Robert Malone, one of the new members of the vaccine advisory committee, has promoted unproven treatments for Covid-19 and measles. Health and Human Services Secretary Robert F. Kennedy Jr.'s remaking of the vaccine advisory committee represents a clear and present danger to public health. Last week, RFK Jr. disbanded the entire 17-member Advisory Committee on Immunization Practices, known as ACIP. He then replaced the ousted members with eight people of his own choosing. The new members include Robert Malone, a former mRNA researcher who parlayed conspiracy theories about Covid-19 vaccines during the pandemic and has promoted unproven, alternative treatments for both Covid and measles. Other advisors include Martin Kulldorff, also an opponent of Covid shots and co-author of the Great Barrington Declaration, which advocated a herd immunity approach to the pandemic. The speed at which these new members were chosen raised red flags among experts. Until now, potential ACIP appointees were often vetted in a lengthy process that took more than a year to ensure they were qualified and didn't face any potential conflicts of interest. However, several of the new ACIP members don't have any expertise in vaccines or infectious disease, and two of them served as paid experts in a lawsuit against Merck involving its HPV vaccine. The new members are expected to convene at a scheduled ACIP meeting in Atlanta next week. The committee has been giving advice to doctors and patients on vaccination for 60 years. That advice is used by local governments for help in developing policies for schools that keep children safe and by health insurers to determine which vaccines they'll pay for and which they won't. The stakes of this advice is high because vaccination saves lives. Researchers at the Centers for Disease Control and Prevention estimated that giving routine vaccinations to children saved 1.1 million lives between 1994 and 2023. The shots also prevented about 508 million illnesses and 32 million hospitalizations in that time period. This past March, 6,653 foreign citizens, educated at foreign medical schools, matched to internships at American hospitals, according to data from the NRMP. Hasiba Karimi was supposed to be seeing patients at a Harrisburg, Pennsylvania hospital in just a few weeks. She is one of 144 foreign-born international medical school graduates who were slated to start their first year of residency in Pennsylvania this year, and are part of a solution to the critical shortage of doctors in the United States. But she won't be stateside anytime soon. That's because Karimi, who lives in Canada and got her medical education in Turkey, was born in Afghanistan. She was scheduled for an H-1B visa appointment on June 9, the same day President Donald Trump's executive order barring individuals from 19 specific countries from entering the United States took effect. While the order outlines some exceptions—including for diplomatic visas; athletes, coaches and relatives traveling for competitions; and for ethnic and religious minorities 'facing persecution in Iran'—it does not carve out an exception for doctors. So now Karimi, who spent years building her experience and resume to win this internship, can only wait and hope. 'One in four pediatric residents in the USA are international medical school graduates, and they are filling those spots in the most underserved communities that American graduates are not even applying to,' says Sebastian Arruarana, a resident physician at the Brookdale University Hospital and Medical Center in Brooklyn, New York, and an advocate for international medical graduates. 'If this is not solved, who will take care of our children?' Read more here. A gene editing therapy for severe hemophilia B showed promising results in a new study published last week in the New England Journal of Medicine. Between 2010 and 2012, 10 patients who had severe hemophilia B caused by a defect in their DNA that prevented their bodies from making Factor IX, a key blood clotting agent, received the therapy manufactured by St. Jude Research. The treatment they received included the correct gene. Prior to treatment, the patients required regular injections of Factor IX in order to prevent bleeding episodes. The NEJM study found that more than a decade later, the patients who received this gene therapy were still producing Factor IX. Seven of the patients were able to discontinue injections while the others were able to significantly reduce the amount needed. All reported far fewer bleeding incidents with no significant side effects from the medication. Because gene therapies are so expensive (often in the millions of dollars) a big question is whether a single administration can last without the need for additional doses. This study's findings show that it's possible for a treatment to remain durable for more than a decade, which is an encouraging finding for this class of medicine. Plus: 23andMe founder Anne Wojcicki will buy back the assets of the company from bankruptcy. She beat out Regeneron Pharmaceuticals with a $305 million bid. And Caris Life Sciences went public on Wednesday, raising $494 million at an expected valuation of more than $5 billion. Digital health startup Sword Health raised $40 million led by General Catalyst at a valuation of $4 billion. The company said it plans to use the new capital to expand its services to mental health care. It announced the launch of a new product, called Mind, that it said would combine an AI 'therapist' with human professionals. On Sunday, a patient in Angola received surgery for his prostate cancer. The team that performed the operation, meanwhile, was in Orlando, Florida–about 7,000 miles away. This was the first intercontinental operation of its kind to be approved by the FDA for a clinical trial of remote robotic surgery. The purpose of the test was to see if robotic surgery of this type could be performed at that distance using fiberoptic cables. The procedure was a success, which could pave the way for more remote procedures, increasing healthcare access in countries lacking in doctors and other resources. The Supreme Court on Wednesday upheld a Tennessee ban on transgender care for minors. The justices voted 6-to-3 that limiting access to treatments such as puberty blockers for those under the age of 18 was not sex discrimination. The ruling, written by Justice John Roberts, comes as the Trump Administration has attacked transgender rights and could have an effect on two dozen other states with similar laws on the books. Leading medical groups endorse treatments for gender dysphoria. A federal judge ruled that hundreds of NIH grant terminations were 'void and illegal.' 'I have never seen racial discrimination by the government like this,' Judge William Young said from the bench. A coalition of academic groups proposed an alternative for NIH indirect cost reform in response to the Trump Administration's proposed slashing of billions in research overhead payments. Sarepta and Roche stopped the use of Duchenne muscular dystrophy therapy gene therapy Elevidys following two patients' deaths. The governor of Oregon signed a law enacting the country's strictest limits on private equity takeovers of medical practices. Germany's BioNTech agreed to buy rival CureVac to boost cancer research in $1.25 billion deal. South Africa built a medical research powerhouse. Trump's budget cuts have demolished it – and could threaten global progress on everything from heart disease to HIV. Digital startup Tennr raised $101 million at an undisclosed valuation to expand development of its software platform, which lets healthcare services automate and manage their faxes. (Yes, faxes–they're still a thing in healthcare.)
Washington Post
33 minutes ago
- Washington Post
More employers are sending workers shopping for their own health coverage
A small, growing number of employers are putting health insurance decisions entirely in the hands of their workers. Instead of offering traditional insurance, they're giving workers money to buy their own coverage in what's known as Individual Coverage Health Reimbursement Arrangements, or ICHRAs . Advocates say this approach provides small companies that couldn't afford insurance a chance to offer something. It also caps a growing expense for employers and fits conservative political goals of giving people more purchasing power over their coverage. But ICHRAs place the risk for finding coverage on the employee, and they force them to do something many dislike: Shop for insurance. 'It's maybe not perfect, but it's solving a problem for a lot of people,' said Cynthia Cox, of the nonprofit KFF, which studies health care issues. Here's a closer look at how this approach to health insurance is evolving. Normally, U.S. employers offering health coverage will have one or two insurance options for workers through what's known as a group plan. The employers then pick up most of the premium, or cost of coverage. ICHRAs are different: Employers contribute to health insurance coverage, but the workers then pick their own insurance plans. The employers that use ICHRAs hire outside firms to help people make their coverage decisions. ICHRAs were created during President Donald Trump's first administration. Enrollment started slowly but has swelled in recent years. They give business owners a predictable cost, and they save companies from having to make coverage decisions for employees. 'You have so many things you need to focus on as a business owner to just actually grow the business,' said Jeff Yuan, co-founder of the New York-based insurance startup Taro Health. Small businesses, in particular, can be vulnerable to annual insurance cost spikes, especially if some employees have expensive medical conditions. But the ICHRA approach keeps the employer cost more predictable. Yuan's company bases its contributions on the employee's age and how many people are covered under the plan. That means it may contribute anywhere from $400 to more than $2,000 monthly to an employee's coverage. ICHRAs let people pick from among dozens of options in an individual insurance market instead of just taking whatever their company offers. That may give people a chance to find coverage more tailored to their needs. Some insurers, for instance, offer plans designed for people with diabetes. And workers can keep the coverage if they leave — potentially for longer periods than they would be able to with traditional employer health insurance plans. They likely will have to pay the full premium, but keeping the coverage also means they won't have to find a new plan that covers their doctors. Mark Bertolini, CEO of the insurer Oscar Health, noted that most people change jobs several times. 'Insurance works best when it moves with the consumer,' said the executive, whose company is growing enrollment through ICHRAs in several states. Health insurance plans on the individual market tend to have narrower coverage networks than employer-sponsored coverage. It may be challenging for patients who see several doctors to find one plan that covers them all. People shopping for their own insurance can find coverage choices and terms like deductibles or coinsurance overwhelming. That makes it important for employers to provide help with plan selection. The broker or technology platform setting up a company's ICHRA generally does this by asking about their medical needs or if they have any surgeries planned in the coming year. There are no good numbers nationally that show how many people have coverage through an ICHRA or a separate program for companies with 50 workers or less. However, the HRA Council, a trade association that promotes the arrangements, sees big growth. The council works with companies that help employers offer the ICHRAs. It studies growth in a sample of those businesses. It says about 450,000 people were offered coverage through these arrangements this year. That's up 50% from 2024. Council Executive Director Robin Paoli says the total market may be twice as large. Still, these arrangements make up a sliver of employer-sponsored health coverage in the United States. About 154 million people were enrolled in coverage through work last year, according to KFF. Several things could cause more employers to offer ICHRAs. As health care costs continue to climb, more companies may look to limit their exposure to the hit. Some tax breaks and incentives that encourage the arrangements could wind up in a final version of the Republican tax bill currently under consideration in the Senate. More people also will be eligible for the arrangements if extra government subsidies that help buy coverage on the Affordable Care Act's individual marketplaces expire this year. You can't participate in an ICHRA if you are already getting a subsidy from the government, noted Brian Blase, a White House health policy adviser in the first Trump administration. 'The enhanced subsidies, they crowd out private financing,' he said. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group. The AP is solely responsible for all content.
